NCR Online Journal

Hear the Leading Oncologist, Jeff Geschwind, in Stockholm on the Leading Cancer Issues

 Breaking News
  • No posts were found

Hear the Leading Oncologist, Jeff Geschwind, in Stockholm on the Leading Cancer Issues

March 10
15:09 2023

Jeff Geschwind is addressing the public in Stockholm on the ECIO 2023. Learn about the current issues in Oncology and Image-Guided Therapy with Jeff

 

European Conference on Interventional Oncology (ECIO) 2023 is organizing in Stockholm this time. Numerous doctors, surgeons, oncologists, and leading professionals in the medical industry will address the audience on the current cancer issues and progressions on their cures. As the event will feature many reputable and honorable medical experts, one of them is internationally recognized Jeff Geschwind.

Jeff is a prominent name in liver cancer and is the author of the first book on Interventional Oncology. He is currently the medical director in Image-Guided Therapy and Oncology at Syntactx and the oncology director at USA Clinics Group. He is also a leading scientist in various research organizations, working for the welfare of human beings.

At the event, he will be representing as the medical director of the leading MedTech CRO provider, NAMSA. The organization offers medical device tests, quality regulations, product development strategies, clinical research, In vitro diagnostics products development, and many other operations.

Jeff Geschwind is a fine resource of NAMSA, ready to offer special lectures on liver cancer in Stockholm. Jeff has already published almost 300 scientific manuscripts. He was the head of the Radiology and Biomedical Imaging Department at Yale School of Medicine and a senior professor at John Hopkins University.

 

He has received many national and international awards. Some honorable mentions are the Alexander Margulis Award, the Gary Becker Young Investigator Award, the American Roentgen Ray Society Fellowship Award, and the Alumni Awards at Boston University and the University of California San Francisco.

Mr. Geschwind is a significant figure in the field of oncology, leading and co-investigating 50+ clinical trials. Many pharmaceutical companies, NGOs, foundations, and even the National Institute of Health (NIH) have facilitated these trials and are working on many effective patents of cancer-cure drugs.

Jeff also actively participates in many Radiology and Cardiovascular journals at NAMSA provides valuable reviews, and is included among the top US doctors. Recently, he has been working on many essential projects, like breast cancer cryoablation, ultrasound-guided therapy, Endobronchial therapy, and therapy using radioactive microspheres.

ECIO 2023 also features more than 150 lectures from 120+ respected faculty members, providing hands-on training for 20 devices. Apart from Jeff’s speaking on liver cancer, the event will also include AI in interventional oncology, Hepatocellular carcinoma, Immuno-oncology, Musculoskeletal, and others. These lectures will be presented by famous names in the medical field, including Andreas Adam, Dirk Arnold, Alex Barnacle, and Roberto Iezzi.

For more information, visit ECIO 2023 official website.

Media Contact
Company Name: Jeffgeschwind
Contact Person: Jeff Geschwind
Email: Send Email
Phone: +1 410 446 9061
City: New York
Country: United States
Website: www.jeffgeschwind.com